Nutex Health Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $846.7M+76.4% YoYTTM through 30 Jun 2026
Net Income $179.9M+245.4% YoYTTM through 30 Jun 2026
Free Cash Flow $274.2MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 42.4% |
| EBITDA Margin | 45.5% |
| Operating Margin | 37.5% |
| Net Margin | 21.3% |
Returns
45.6%ROE
18.7%ROA
78.7%ROIC
Balance Sheet Health
Debt / Equity0.10x
Current Ratio5.00x
Net Debt-$165.6Mnet cash position
Cash & Equivalents$205.2M
Quality Metrics
Altman Z-Score4.33
Piotroski F-Score7 / 9
FCF Margin32.4%
Rule of 4035.3
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $875.3M
Diluted EPS$25.80TTMFY2025: $10.48
Dividend
No dividend
Capital Allocation
Capex Intensity0.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Hospital Division | $844.2M | View detailsPlans to open four new hospital facilities in 2026. | |
| Population Health Management Division | $31.1M | View detailsPlans to launch one to three additional IPAs per year. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.